Buscar
Mostrando ítems 11-20 de 329
Dual role of IL-12 in the therapeutic efficacy or failure during combined PEG-Interferon-α2A and ribavirin therapy in patients with chronic hepatitis C
(Elsevier/North-Holland Biomedical Press, 2018)
The H63D genetic variant of the HFE gene is independently associated with the virological response to interferon and ribavirin therapy in chronic hepatitis C
(LIPPINCOTT WILLIAMS & WILKINS, 2010)
Background Conflicting results have been reported in studies evaluating the relationship between serum markers of iron overload, liver iron deposits, and HFE mutations (C282Y and H63D) in chronic hepatitis C patients, and ...
Inflammation response and liver stiffness: predictive model of regression of hepatic stiffness after sustained virological response in cirrhotics patients with chronic hepatitis C
(2021-01-01)
Cirrhotic patients with chronic hepatitis C should be monitored for the evaluation of liver function and screening of hepatocellular carcinoma even after sustained virological response (SVR). The stage of inflammatory ...
Insulin resistance, hepatic steatosis and hepatitis C: A complex relationship with relevant clinical implications
(ELSEVIER ESPANA, 2010)
Insulin resistance (IR) is a common pathophysiological condition where higher-than-normal concentrations of insulin are needed to maintain a normal glycemia and adequate glucose utilization in insulin target tissues. A ...
Direct-acting antiviral agents for HCV-associated glomerular disease and the current evidence
(Molecular Diversity Preservation International, 2019-10)
Glomerular disease is an extra-hepatic manifestation of hepatitis C virus infection (HCV) and membranoproliferative glomerulonephritis is the most frequent glomerular disease associated with HCV. It occurs commonly in ...